Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
-
Published:2024-10
Issue:
Volume:147
Page:107173
-
ISSN:1201-9712
-
Container-title:International Journal of Infectious Diseases
-
language:en
-
Short-container-title:International Journal of Infectious Diseases
Author:
Thanh Tran TanORCID, Tu Nguyen Thi Kha, Nguyet Lam Anh, Thuy Cao Thu, Thuan Nguyen Lam Thai, Ny Nguyen Thi Han, Nhu Le Nguyen TrucORCID, Thanh Le Kim, Hong Nguyen Thi Thu, Anh Nguyen To, Truong Nguyen Thanh, Chau Nguyen Van Vinh, Yen Lam Minh, Van E Phan, Thuong Nguyen Phong, Van Truc Nguyen, Trung Pham Huu, Yap Wee CheeORCID, Pandey Rahul, Yee Sidney, Weng Ruifen, Mongkolsapaya Juthathip, Dejnirattisai Wanwisa, Hamers Raph L, Chantratita Narisara, Screaton Gavin, Dunachie Susanna J, Jones E Yvonne, Stuart David I, Dung Nguyen Thanh, Thwaites Guy, Wang Lin-Fa, Tan Chee Wah, Tan Le VanORCID
Reference22 articles.
1. Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: a randomised, double-blind, placebo-controlled, phase 1–2 clinical trial (ABDALA Study);Hernández-Bernal;EClinicalmedicine,2022 2. A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study);Hernández-Bernal;Lancet Reg Health Am,2023 3. COVID-19 vaccine development and approvals tracker;Basta,2020 4. Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3–18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study);Cinza-Estévez;EClinicalmedicine,2023 5. Cuban Abdala vaccine: effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; a cohort study;Mas-Bermejo;Lancet Reg Health Am,2022
|
|